167 related articles for article (PubMed ID: 7597124)
1. Comparative behavioral characterization of the neuroactive steroids 3 alpha-OH,5 alpha-pregnan-20-one and 3 alpha-OH,5 beta-pregnan-20-one in rodents.
Wieland S; Belluzzi JD; Stein L; Lan NC
Psychopharmacology (Berl); 1995 Mar; 118(1):65-71. PubMed ID: 7597124
[TBL] [Abstract][Full Text] [Related]
2. Behavioral characterization of Co 134444 (3alpha-hydroxy-21-(1'-imidazolyl)-3beta-methoxymethyl-5alpha- pregnan-20-one), a novel sedative-hypnotic neuroactive steroid.
Vanover KE; Hogenkamp DJ; Lan NC; Gee KW; Carter RB
Psychopharmacology (Berl); 2001 May; 155(3):285-91. PubMed ID: 11432691
[TBL] [Abstract][Full Text] [Related]
3. Anxiolytic and anticonvulsant activity of a synthetic neuroactive steroid Co 3-0593.
Wieland S; Belluzzi J; Hawkinson JE; Hogenkamp D; Upasani R; Stein L; Wood PL; Gee KW; Lan NC
Psychopharmacology (Berl); 1997 Nov; 134(1):46-54. PubMed ID: 9399366
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo activity of 16,17-dehydro-epipregnanolones: 17,20-bond torsional energy analysis and D-ring conformation.
Bolger MB; Wieland S; Hawkinson JE; Xia H; Upasani R; Lan NC
Pharm Res; 1996 Oct; 13(10):1488-94. PubMed ID: 8899839
[TBL] [Abstract][Full Text] [Related]
5. Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone.
Beekman M; Ungard JT; Gasior M; Carter RB; Dijkstra D; Goldberg SR; Witkin JM
J Pharmacol Exp Ther; 1998 Mar; 284(3):868-77. PubMed ID: 9495844
[TBL] [Abstract][Full Text] [Related]
6. Genetic differences in behavioral sensitivity to a neuroactive steroid.
Finn DA; Roberts AJ; Lotrich F; Gallaher EJ
J Pharmacol Exp Ther; 1997 Feb; 280(2):820-8. PubMed ID: 9023296
[TBL] [Abstract][Full Text] [Related]
7. Anxiolytic properties of endogenously occurring pregnanediols in two rodent models of anxiety.
Carboni E; Wieland S; Lan NC; Gee KW
Psychopharmacology (Berl); 1996 Jul; 126(2):173-8. PubMed ID: 8856837
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3alpha, 21-dihydroxy-3beta-trifluoromethyl-19-nor-5beta-pregnan-20-one), a selective modulator of gamma-aminobutyric acid(A) receptors.
Vanover KE; Rosenzweig-Lipson S; Hawkinson JE; Lan NC; Belluzzi JD; Stein L; Barrett JE; Wood PL; Carter RB
J Pharmacol Exp Ther; 2000 Oct; 295(1):337-45. PubMed ID: 10991999
[TBL] [Abstract][Full Text] [Related]
9. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic activity of the progesterone metabolite 5 alpha-pregnan-3 alpha-o1-20-one.
Wieland S; Lan NC; Mirasedeghi S; Gee KW
Brain Res; 1991 Nov; 565(2):263-8. PubMed ID: 1688192
[TBL] [Abstract][Full Text] [Related]
11. Anxiolytic effects of the neuroactive steroid pregnanolone (3 alpha-OH-5 beta-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum.
Bitran D; Dugan M; Renda P; Ellis R; Foley M
Brain Res; 1999 Dec; 850(1-2):217-24. PubMed ID: 10629767
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor.
Bitran D; Hilvers RJ; Kellogg CK
Brain Res; 1991 Oct; 561(1):157-61. PubMed ID: 1686744
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of in vivo interactions in mice between flurazepam and two neuroactive steroids.
Deutsch SI; Rosse RB; Steinberg K; Morn C; Koetzner L; Riggs R; Mastropaolo J
Pharmacol Biochem Behav; 1996 Nov; 55(3):323-6. PubMed ID: 8951972
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.
Carter RB; Wood PL; Wieland S; Hawkinson JE; Belelli D; Lambert JJ; White HS; Wolf HH; Mirsadeghi S; Tahir SH; Bolger MB; Lan NC; Gee KW
J Pharmacol Exp Ther; 1997 Mar; 280(3):1284-95. PubMed ID: 9067315
[TBL] [Abstract][Full Text] [Related]
15. Modification of behavioral effects of drugs in mice by neuroactive steroids.
Ungard JT; Beekman M; Gasior M; Carter RB; Dijkstra D; Witkin JM
Psychopharmacology (Berl); 2000 Mar; 148(4):336-43. PubMed ID: 10928304
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of a 17β-heteroaryl-substituted neuroactive steroid.
Hogenkamp DJ; Tran MB; Yoshimura RF; Johnstone TB; Kanner R; Gee KW
Psychopharmacology (Berl); 2014 Sep; 231(17):3517-24. PubMed ID: 24682501
[TBL] [Abstract][Full Text] [Related]
17. CCD-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat.
Edgar DM; Seidel WF; Gee KW; Lan NC; Field G; Xia H; Hawkinson JE; Wieland S; Carter RB; Wood PL
J Pharmacol Exp Ther; 1997 Jul; 282(1):420-9. PubMed ID: 9223583
[TBL] [Abstract][Full Text] [Related]
18. Benzodiazepine and neuroactive steroid combinations in rats: anxiolytic-like and discriminative stimulus effects.
Gunter BW; Jones SA; Paul IA; Platt DM; Rowlett JK
Psychopharmacology (Berl); 2016 Sep; 233(17):3237-47. PubMed ID: 27356519
[TBL] [Abstract][Full Text] [Related]
19. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
[TBL] [Abstract][Full Text] [Related]
20. Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice.
Rodgers RJ; Johnson NJ
Pharmacol Biochem Behav; 1998 Jan; 59(1):221-32. PubMed ID: 9443559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
